Dr. Eric Gauthier

Office: F-524
Lab: S-412

Mailing Address:
Dr. E. Gauthier
Department of Chemistry & Biochemistry
Laurentian University
Sudbury, ON
P3E 2C6

Telephone:
Voice: (705) 675-1151, ext 2119, 2102
FAX: (705) 675-4844

Internet:
egauthier@laurentienne.ca
http://go.to/celldeath

Current position

Associate Professor, Department of Chemistry and Biochemistry, Laurentian University

Cross-appointment, Department of Biology, Laurentian University


Education and Training


1998-present: Associate Professor of Biochemistry
Department of Chemistry and Biochemistry, Laurentian University

1994-1998: Assistant Professor of Biochemistry
Department of Chemistry and Biochemistry, Laurentian University

1993-1994 Postdoctoral Fellow
Canadian Red Cross Society, Quebec City Blood Service, Division of Research and Development, Ste-Foy (Quebec, Canada)

1988-1993 Ph.D. Molecular and Cellular Biology
Biohormonal Regulation Laboratory, Laval University Hospital Center, Ste-Foy (Quebec, Canada)

1985-1988 B.Sc. Biochemistry
Université du Québec à Trois-Rivières, Trois-Rivières (Quebec, Canada)


Research Funding


Natural Sciences and Engineering Research Council of Canada
Ontario Research and Development Challenge Fund
Laurentian University Research Fund

Research staff


Name Position E-mail
Curtis Harnett Graduate student cc_harnett@laurentian.ca
Matthew Mallory Graduate student mt_mallory@laurentian.ca

 

Research Investigations


Amino Acids and Cell Survival
We are interested in the molecular and cellular events involved in the initiation, execution and regulation of cell death in mammalian cells. Our research program focuses on two main facets of this problem: a more fundamental aspect, where we investigate the intracellular signals triggered by amino acids, and a more applied focus, where the impact of the modulation of cell death on the behavior of hybridoma cells is investigated.

  1. Understanding the molecular events responsible for the induction of cell death upon deprivation of the amino acid L-glutamine.
    It has been known for the past 50 years that L-glutamine is required for mammalian cell survival. Not only is this amino acid essential for the growth of most cultured cell lines, but decreased blood glutamine levels (resulting from catabolic stress following severe trauma or malnourishment) has also been shown to sensitize cells to undergo programmed cell death, contributing to several diseases such as sepsis, intestinal atrophy and immunodeficiency. Furthermore, glutamine supplementation has been shown to improve the state of the immune system and to prevent some of the side effect associated with chemo/radiotherapy. Surprisingly, the molecular basis of glutamine-mediated cell survival is still poorly understood. We are using several cell models (mouse hybridomas, intestinal epithelial cells, neutrophils) in an effort to uncover the molecular pathways underlying the role of L-glutamine as a survival factor. A major focus of our current work is to characterize the cellular "glutamine sensors" which link intracellular glutamine levels to cell survival.
  2. Optimization of biotechnologically-relevant mammalian cell lines. Mammalian cell culture is widely used to produce large amounts of proteins of biotechnological or biomedical interest (e.g. monoclonal antibodies). However, cell death by apoptosis has been shown to severely limit the productivity of these cells, both in batch or perfusion cultures. While the induction of apoptotic cell death in long-term culture can be attributed to several factors, the exhaustion of amino acids, notably L-glutamine, from the culture media constitutes an important trigger. New means to improve the viability of cultured cell lines are therefore being sought, either by modifying culture conditions or genetically altering the cells themselves.
    One aspect of our research program in centered on investigating the role which apoptosis plays in limiting the viability of cell lines in culture. In particular, we are exploring the molecular pathways responsible for apoptosis in long-term cultured cells. Our goal is to use this newly acquired knowledge to improve cell viability using genetic engineering techniques (e.g. ectopic gene expression). We are also exploring the molecular basis of apoptosis induction in hybridoma cells. Finally, one aspect of our research is to determine the impact that the gene expression profile specific to each hybridoma cell line can have on cell behavior and productivity.

 

Selected publications


Paquette, J. C., P.J. Guérin, and E.R. Gauthier. (2005). Rapid induction of the intrinsic apoptotic pathway by L-glutamine starvation. J. Cell. Physiol. 202 (3): 912-921). [Abstract]

Charbonneau, J.R., T. Furtak, J. Lefebvre and E.R. Gauthier. (2003). Bcl-xL expression interferes with the effects of L-glutamine supplementation on hybridoma cultures. Biotechnology and Bioengineering. 81: 279-290. [Pubmed]

Charbonneau, J. and E.R. Gauthier. (2001). Protection of hybridoma cells against apoptosis by a loop domain-deficient Bcl-xL protein. Cytotechnology. 37: 41-47.[Abstract]

Charbonneau, J. and E.R. Gauthier. (2000). Prolongation of hybridoma cell viability in stationary batch culture by Bcl-xL expression. Cytotechnology. 34(1-2): 131-39.[Abstract]

Gauthier, E.R., L. Piché, G. Lemieux and R. Lemieux. (1996). Role of bcl-xL in the control of apoptosis in murine myeloma cells. Cancer Research. 56: 1451-1456.[Pubmed]